On November 3, 2020, Lanhai Medical Investment Co., Ltd. (SHSE:600896) closed the transaction. The company issued 155,706,344 share at a issue price of CNY 3.78 for gross proceeds of CNY 588,569,980.32. The transaction included participation from returning investor Shanghai Lanhai Investment Co., Ltd. for 79,365,079 share for CNY 299, 999,998.62, Yang Zhongyi for 21,634,920 shares for CNY 81,999,997.38, Yang Junmin for 20,634,920 shares for CNY 77,999,997.60, Kaohsiung for 13,227,513 shares for CNY 49,999,999.14, Wang Ping for 6,613,756 shares for CNY 24,999,997.68, Li Mingzhu for 4,761,904 shares for CNY 17,999,997.12, Zhang Weiyuan for 2,645,502 shares for CNY 9,999,997.56, Yang Yuezhi for 2,116,402 shares for CNY 7,999,999.56, Sang Jianping for 2,000,000 shares for CNY 7,560,000.00, Chen Jian for 1,058,201 shares for CNY 3,999,999.78, Bao Min for 531,746 shares for CNY 2,009,999.88, Lin Dewei for 529,100 shares for CNY 1,999,998.00, Wang Ganlin for 529,100 shares for CNY 1,999,998.00. The company paid issuance cost of CNY 5,712,930.50 in the transaction.